Existing customer? Sign in
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Funding Rounds
$150,000,000
May 2022
$86,000,000
April 2020